A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in dwarf rats: Reversal of the profiles by growth hormone-treatment

Archives of Biochemistry and Biophysics

Volumn 337, Issue 1, 1997, Pages 34-42

  Shimada, Miki ^a   Murayama, Norie ^b   Nagata, Kiyoshi ^a   Hashimoto, Hisashi ^c   Ishikawa, Hiroshi ^c   Yamazoe, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

dwarf rat; GH regulation; P450; sex difference

Indexed keywords

CYTOCHROME B5; CYTOCHROME P450; GROWTH HORMONE; LIVER ENZYME; MESSENGER RNA; PHENOBARBITAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE;

ANIMALIA;

EID: 0030900433     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1996.9764     Document Type: Article

References (45)

1. 1. Kato, R., and Yamazoe, Y. (1993) in Handbook of Experimental Pharmacology, 105 Cytochrome P450 (Schenkman, J. B., and Greim, H., Eds.), pp. 447-459, Springer-Verlag, Heidelberg.
2. 2. Wilson, J. T., and Frohman, L. A. (1974) J. Pharm. Exp. Ther. 189, 255-270.
3. 3. Colby, H. D. (1980) in Advances in Sex Hormone Research (Thomas, J. A., and Singhal, R. L., Eds.), pp. 27-71, Urban & Schwarzenberg, München.
4. 4. Gustafsson, J.-Å., Mode, A., Norstedt, G., and Skett, P. (1983) Annu. Rev. Physiol. 45, 51-60.
5. 5. Okuma, S., and Kawashima, S. (1980) Exp. Anim. 29, 301-303.
6. 6. Nogami, H., Takeuchi, T., Suzuki, K., Okuma, S., and Ishikawa, H. (1989) Endocrinology 125, 964-970.
7. 7. Takeuchi, T., Suzuki, H., Sakurai, S., Nogami, H., Okuma, S., and Ishikawa, H. (1990) Endocrinology 126, 31-38.
8. 8. Legraverend, C., Mode, A., Wells, T., Robinson, I., and Gustafsson, J.-Å. (1992) FASEB J. 6, 711-718.
9. 9. Bullock, P., Gemzik, B., Johnson, D., Thomas, P., and Parkinson, A. (1991) Proc. Natl. Acad. Sci. USA 88, 5227-5231.
10. 10. Laemmli, U. K. (1970) Nature 227, 680-685.
11. 11. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. USA 76, 4350-4354.
12. 12. Kamataki, T., Maeda, K., Yamazoe, Y., Nagai, T., and Kato, R. (1983) Arch. Biochem. Biophys. 225, 758-770.
13. 13. Kamataki, T., Maeda, K., Yamazoe, Y., Matsuda, N., Ishii, K., and Kato, R. (1983) Mol. Pharmacol. 24, 146-155.
14. 14. Kawano, S., Kamataki, T., Yasumori, T., Yamazoe, Y., and Kato, R. (1987) J. Biochem. 102, 493-501.
15. 15. Blake, M. S., Johnston, K. H., Russell-Jones, G. J., and Gotschlich, E. C. (1984) Anal. Biochem. 136, 175-179.
16. 16. Nagata, K., Gonzalez, F. J., Yamazoe, Y., and Kato, R. (1990) J. Biochem. 107, 718-725.
17. 17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275.
18. 18. Kamataki, T., Shimada, M., Maeda, K., and Kato, R. (1985) Biochem. Biophys. Res. Commun. 130, 1247-1253.
19. 19. Phillips, A. H., and Langdon, R. G. (1962) J. Biol. Chem. 237, 2652-2660.
20. 20. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979) Biochemistry 18, 5294-5299.
21. 21. Shimada, M., Murayama, N., Yamauchi, K., Yamazoe, Y., and Kato, R. (1989) Arch. Biochem. Biophys. 270, 578-587.
22. 22. Sasamura, H., Nagata, K., Yamazoe, Y., Shimada, M., Saruta, T., and Kato, R. (1990) Mol. Cell. Endocrinol. 68, 53-60.
23. 23. Shimada, M., Nagata, K., Murayama, N., Yamazoe, Y., and Kato, R. (1989) J. Biochem. 106, 1030-1034.
24. 24. Nagata, K., Murayama, N., Miyata, M., Shimada, M., Urahashi, A., Yamazoe, Y., and Kato, R. (1996) Pharmacogenetics 6, 103-111.
25. 25. Waxman, D. J., Morrissey, J. J., and LeBlanc, G. A. (1989) Mol. Pharmacol. 35, 519-525.
26. 26. Miyata, M., Nagata, K., Shimada, M., Yamazoe, Y., and Kato, R. (1994) Arch. Biochem. Biophys. 314, 351-359.
27. 27. MacGeoch, C., Morgan, E. T., and Gustafsson, J.-Å. (1985) Endocrinology 117, 2085-2092.
28. 28. Morgan, E. T., MacGeoch, C., and Gustafsson, J.-Å. (1985) Mol. Pharmacol. 27, 471-479.
29. 29. Kato, R., Yamazoe, Y., Shimada, M., Murayama, N., and Kamataki, T. (1986) J. Biochem. 100, 895-902.
30. 30. Yamazoe, Y., Shimada, M., Kamataki, T., and Kato, R. (1986) Jpn. J. Pharmacol. 42, 371-382.
31. 31. Yamazoe, Y., Shimada, M., Murayama, N., and Kato, R. (1987) J. Biol. Chem. 262, 7423-7428.
32. 32. Yamazoe, Y., Shimada, M., Murayama, N., Kawano, S., and Kato, R. (1986) J. Biochem. 100, 1095-1097.
33. 33. Yamazoe, Y., Murayama, N., Shimada, M., Imaoka, S., Funae, Y., and Kato, R. (1989) Mol. Pharmacol. 36, 716-722.
34. 34. Yamazoe, Y., Ling, X., Murayama, N., Gong, D., Nagata, K., and Kato, R. (1990) J. Biochem. 108, 599-603.
35. 35. Nemeroff, C. B., Konkol, R. J., Bissette, G., Youngblood, W., Martin, J. B., Brazeau, P., Rone, M. S., Prange, A. J., Breese, G. R., and Kizer, J. S. (1977) Endocrinology 101, 613-622.
36. 36. Millard, W. J., Martin, J. B. J., Audet, J., Sager, S. M., and Martin, J. B. (1982) Endocrinology 110, 540-550.
37. 37. Terry, L. C., Epelbaum, J., and Martin, J. B. (1981) Brain Res. 217, 129-142.
38. 38. Shapiro, B. H., Albucher, R. C., Macleod, J. N., and Bitar, M. S. (1986) Drug Metab. Dispos. 14, 585-589.
39. 39. Yamazoe, Y., Shimada, M., Murayama, N., Yamauchi, K., and Kato, R. (1988) Biochem. Pharmacol. 37, 1687-1691.
40. 40. Waxman, D. J., Morrissey, J. J., Macleod, J. N., and Shapiro, B. H. (1990) Endocrinology 126, 712-720.
41. 41. Yamazoe, Y., Murayama, N., Shimada, M., Yamauchi, K., Nagata, K., Imaoka, S., Funae, Y., and Kato, R. (1988) J. Biochem. 104, 785-790.
42. 42. Wood, W. A., Ryan, D. E., Thomas, P. E., and Levin, W. (1983) J. Biol. Chem. 258, 8839-8847.
43. 43. Shimada, M., Murayama, N., Yamazoe, Y., Hashimoto, H., Ishikawa, H., and Kato, R. (1995) J. Pharmacol. Exp. Ther. 275, 972-977.
44. 44. Yamazoe, Y., Murayama, N., Shimada, M., and Kato, R. (1989) Biochem. Biophys. Res. Commun. 160, 609-614.
45. 45. Murayama, N., Shimada, M., Yamazoe, Y., and Kato, R. (1991) Mol. Pharmacol. 39, 811-817.